238 related articles for article (PubMed ID: 16998588)
1. Transcription factor MITF regulates cardiac growth and hypertrophy.
Tshori S; Gilon D; Beeri R; Nechushtan H; Kaluzhny D; Pikarsky E; Razin E
J Clin Invest; 2006 Oct; 116(10):2673-81. PubMed ID: 16998588
[TBL] [Abstract][Full Text] [Related]
2. [Identification and differential expression of the microphthalmia-associated transcription factor in heart and isolated cardiomyocytes from Guinea pigs: possible role in hypertrophy and viability].
Gunturiz ML; Gómez LA
Biomedica; 2014; 34(3):387-402. PubMed ID: 25504126
[TBL] [Abstract][Full Text] [Related]
3. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
4. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
[TBL] [Abstract][Full Text] [Related]
5. FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy.
Rachmin I; Amsalem E; Golomb E; Beeri R; Gilon D; Fang P; Nechushtan H; Kay G; Guo M; Yiqing PL; Foo RS; Fisher DE; Razin E; Tshori S
Int J Cardiol; 2015 Sep; 195():85-94. PubMed ID: 26025865
[TBL] [Abstract][Full Text] [Related]
6. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
Major JL; Salih M; Tuana BS
J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
[TBL] [Abstract][Full Text] [Related]
7. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
[TBL] [Abstract][Full Text] [Related]
8. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
9. Annexin A7 deficiency potentiates cardiac NFAT activity promoting hypertrophic signaling.
Voelkl J; Alesutan I; Pakladok T; Viereck R; Feger M; Mia S; Schönberger T; Noegel AA; Gawaz M; Lang F
Biochem Biophys Res Commun; 2014 Feb; 445(1):244-9. PubMed ID: 24508799
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
Kuzman JA; O'Connell TD; Gerdes AM
Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
[TBL] [Abstract][Full Text] [Related]
11. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
[TBL] [Abstract][Full Text] [Related]
13. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
[TBL] [Abstract][Full Text] [Related]
15. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
[TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.
Ulm S; Liu W; Zi M; Tsui H; Chowdhury SK; Endo S; Satoh Y; Prehar S; Wang R; Cartwright EJ; Wang X
J Mol Cell Cardiol; 2014 Jul; 72(100):104-16. PubMed ID: 24631771
[TBL] [Abstract][Full Text] [Related]
18. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.
Yoshida T; Yamashita M; Horimai C; Hayashi M
J Biol Chem; 2014 Sep; 289(38):26107-26118. PubMed ID: 25100730
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Effects of Attenuating Gsα - Dependent Signaling.
Streit MR; Weiss CS; Meyer S; Ochs MM; Hagenmueller M; Riffel JH; Buss SJ; Heger T; Katus HA; Hardt SE
PLoS One; 2016; 11(1):e0146988. PubMed ID: 26811901
[TBL] [Abstract][Full Text] [Related]
20. Pax3 target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations.
Corry GN; Underhill DA
Pigment Cell Res; 2005 Dec; 18(6):427-38. PubMed ID: 16280008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]